Advertising

CVE:ASG

0.35
0.02 (5.48%) 1d
0
Showing 1 to 11 of 11 entries
  • «
  • 1
  • »
WATCH

It was all " gung ho" about 2 years ago. It is difficult to find out what is going on. Management have been rather shy for a long time. Overall revenues have not risen dramatically for a long time. There are a lot of competitors. He needs to look more closely into the company.

biotechnology
HOLD

It was really unfortunate in that it came out at the peak of interest in the small medical field related companies, and is competing with 12-13 others. It probably will get taken out.

biotechnology
COMMENT

One of the most disappointing plays. It is kind of at the beginning of this great 2-year bull market in all of these stocks. There are a lot of companies in this sector. They are working hard to try to increase its sales in hospital equipment.

biotechnology
PAST TOP PICK

(Top Pick Mar 31/14, Down 70.59%) It went up and then went down. It is competing with 10 or 12 others. It will be much better later. The original run up was just speculation.

biotechnology
PAST TOP PICK

(A Top Pick Jan 13/14. Down 66.82%.) Had an amazing initial climb based on the clamping of the spinal vertebrae. Probably just had too much of a push. They are now down into the hard work of selling into the hospital systems in the US, which apparently have turned a bit cautious. Have 12 or 13 competitors.

biotechnology
HOLD

Have been getting clearance for their spinal devices in the US, England and most recently in Canada. They are in the build process, exhibiting patients, working hard to get into the hospitals, and have launched an additional product. Have about 12 competitors. The stock ran too far, right in the beginning. He will continue to hold.

biotechnology
HOLD

It went too high too fast. They are simply getting down to work now. You have to be a little patient.

biotechnology
RISKY BUY

This kind of collapsed in a mysterious way in July. Thinks it went too far, too fast. Wait for the recovery for the company to get its nose and head down and get working on the products, and selling into the US hospital space. Have new products and they are getting serious. Thinks it has now stabilized. Speculatively, it could easily double in the next 12 months.

biotechnology
BUY

Medical devices. This is probably one of the better corrections as it has had a phenomenal move. There is a dearth of news on the company. They have FDA approval. Things are kind of slow in hospital orders in the US at the moment. This sounds like an opportunity. A great investment for a retail investor who doesn’t have all that much money.

biotechnology
TOP PICK

Patented, approved technology. A Spinal fusion clamp. 50 or so operations completed.

biotechnology
TOP PICK

Spinal repair, less invasive. He has met them, and the company is run by a man that was formerly a nurse. 55 operations to date and now it has approval from the FDA.

biotechnology
Showing 1 to 11 of 11 entries
  • «
  • 1
  • »

Aurora Spine(ASG-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Aurora Spine is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Aurora Spine(ASG-X) Frequently Asked Questions

What is Aurora Spine stock symbol?

Aurora Spine is a Canadian stock, trading under the symbol ASG-X on the TSX Venture Exchange (ASG-CV). It is usually referred to as TSXV:ASG or ASG-X

Is Aurora Spine a buy or a sell?

In the last year, there was no coverage of Aurora Spine published on Stockchase.

Is Aurora Spine a good investment or a top pick?

Aurora Spine was recommended as a Top Pick by on . Read the latest stock experts ratings for Aurora Spine.

Why is Aurora Spine stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Aurora Spine worth watching?

In the last year, there was no coverage of Aurora Spine published on Stockchase.

What is Aurora Spine stock price?

On 2021-10-15, Aurora Spine (ASG-X) stock closed at a price of $0.345.